John Cullivan Joins PCI Pharma Services as Chief Corporate Development Officer

PCI Focuses on Global Growth to Meet Evolving Client Needs

PCI Pharma Services is pleased to announce that John Cullivan has joined the Company as a new member of the Executive Leadership Team in the role of Chief Corporate Development Officer. John will play a key role in PCI’s growth strategy and will accelerate our M&A, focusing on acquisitions to enhance our capabilities, enter new markets and geographies, and strengthen its portfolio of client solutions.

 John Cullivan Joins PCI Pharma Services as Chief Corporate Development Officer

I look forward to working with John to expand PCI’s global footprint and our offerings to clients, who are bringing life-changing therapies to patients around the world,” said Salim Haffar, CEO, PCI Pharma Services. “John is an M& A expert with significant CDMO experience and a strong track record of success. He brings great value to PCI and our clients, and I am excited to welcome him to the Company.

Mr Cullivan joins PCI with over 20 years of experience in corporate development leadership roles at large global life sciences organizations. Prior to joining PCI, he led Corporate Development at Albany Molecular Research Inc. (AMRI). Before that, he held several leadership positions, including Senior Vice President (SVP) of Corporate Development and Strategy for Lonza; head of Corporate Development and Strategy for Capsugel, where he helped transform the company into a Specialty CDMO; and SVP of Corporate Development and Strategy for Cardinal Health.

I am thrilled to join PCI and build upon the growth and innovation that has brought so much benefit to our clients and the company already,” says Mr. Cullivan. “I look forward to partnering with our talented colleagues to execute an acquisition strategy that strengthens our position as a leading integrated, global supply chain solutions provider founded on a culture of excellence and exceptional client service.

Mr. Cullivan holds an MBA from the Massachusetts Institute of Technology (MIT) Sloan School of Management and a B.S. in Aerospace Engineering from the United States Military Academy at West Point. He is a former captain and air cavalry helicopter pilot in the U.S. Army and a veteran of the Persian Gulf War.

When it comes to pharmaceutical and biopharmaceutical supply chain expertise who do you trust?

Your bridge between life-changing therapies and patients